HELM addresses a problem at the root level of drug discovery. Pharmaceutical and biotech companies are looking at increasingly complex molecules in the search for new therapeutics, testing out RNA- and peptide-based compounds that tap directly into cellular pathways.
The proposal for the CSCS Expert Community originated from the Pistoia Alliance CSCS Project, which ran from November 2012 – April 2014. The CSCS Project completed successfully with the delivery of two commercially available Controlled Substance Compliance Services by ChemAxon/Patcore and Scitegrity.
The video of the webinar is now available (also on the project's resources page). Slide decks of each talk can downloaded from this page.
Having joined the Pistoia Alliance as Executive Director Operations just one week earlier, last week’s annual conference in New York was very much in at the deep end for me. In many respects I was there with the same intention as the majority of the other delegates: to learn more about what the Alliance is, what it has been doing, and what it plans to do next.
HELM wins BioIT World Best Practices Award for Informatics! Congratulations to the whole team.
It was great to see so many of you at the HELM reception at BioIT World. For those who are unable to make it, here are the slides containing the latest news from the project and new HELM implementations.
There have been some exciting developments in the half-month since the Pistoia Alliance face-to-face meeting of the board and operational team. Just today, the fledgling working group on Biomarker Exchange Standards held its third meeting.
So what is the face-to-face meeting of the Pistoia Alliance Board and Operational Team that Michael referred to in his latest entries?
The HELM project is delighted to announce that the quattro research bid has won the recent RFP round.